Outlook Therapeutics Inc. buy melinda
Start price
27.09.20
/
50%
€0.58
Target price
04.11.21
€0.89
Performance (%)
206.09%
End price
05.11.21
€1.76
Summary
This prediction ended on 05.11.21 with a price of €1.76. With a performance of 206.09% the BUY prediction by melinda was a big success. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Outlook Therapeutics Inc. | - | - | - | - |
iShares Core DAX® | -3.935% | -2.628% | 10.013% | 11.951% |
iShares Nasdaq 100 | -3.608% | -9.283% | 20.668% | 35.711% |
iShares Nikkei 225® | -4.513% | -6.951% | 5.241% | 2.602% |
iShares S&P 500 | -2.607% | -4.402% | 20.177% | 37.820% |
According to melinda what are the pros and cons of Outlook Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Outlook Therapeutics Inc. diskutieren
Buy mit Kursziel 0,888
In the thread Trading Outlook Therapeutics Inc.
Die von melinda gewählte maximale Laufzeit wurde überschritten
Stopped prediction by melinda for Outlook Therapeutics Inc.
Outlook Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.24
29.08.23
29.08.23
€1.50
29.08.24
29.08.24
-68.71%
10.12.23
10.12.23
Could be worthwhile Investment >10% per year
Outlook Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.21
02.12.21
02.12.21
€2.00
02.12.22
02.12.22
-17.22%
03.12.22
03.12.22
Could be worthwhile Investment >10% per year